EICHORCondition: Prostate Cancer · Sponsor: SWOG Cancer Research Network
RATIONALE: Androgens can cause the growth of prostate cancer cells. Antiandrogen drugs, such as abiraterone acetate, may lessen the amount of androgens made by the body. It may also stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase II trial is studying the side effects and how well abiraterone acetate works in treating patients with prostate cancer who have undergone initial hormone therapy.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| NEA Medical Clinic - East Matthews | Jonesboro, Arkansas, United States | — |
| Arkansas Cancer Research Center at University of Arkansas for Medical Sciences | Little Rock, Arkansas, United States | — |
| Highlands Oncology Group - Springdale | Rogers, Arkansas, United States | — |
| Kaiser Permanente - Deer Valley | Antioch, California, United States | — |
| Kaiser Permanente - Fremont | Fremont, California, United States | — |
| Kaiser Permanente Fresno Medical Center | Fresno, California, United States | — |
| Kaiser Permanente Medical Center - Hayward | Hayward, California, United States | — |
| Tibotec Therapeutics - Division of Ortho Biotech Products, LP | Marysville, California, United States | — |
| Kaiser Permanente Medical Center - Oakland | Oakland, California, United States | — |
| Kaiser Permanente Medical Center - Redwood City | Redwood City, California, United States | — |
| Kaiser Permanente Medical Center - Richmond | Richmond, California, United States | — |
| Kaiser Permanente Medical Center - Roseville | Roseville, California, United States | — |
+ 193 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01309672